ADGRE2 |
Adhesion G protein–coupled receptor E2 |
ASM |
Aggressive Systemic mastocytosis |
ASXL1 |
ASXL Transcriptional Regulator 1 |
BST |
basal serum tryptase |
CBL |
Cbl Proto-Oncogene |
CM |
Cutaneous mastocytosis |
DNMT3A |
DNA Methyltransferase 3 Alpha |
ECD |
Extracellular domain of KIT |
EZH2 |
Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit |
HSC |
hematopoietic stem cells |
HαT |
hereditary alpha-tryptasemia |
HVA |
Hymenoptera venom allergy |
ISM |
Indolent systemic mastocytosis |
JMD: |
Juxtamembrane domain of KIT |
KID |
Kinase insert domain of KIT |
KIT |
KIT Proto-Oncogene, Receptor Tyrosine Kinase |
MCL |
Mast cell leukemia |
MC |
Mast cells |
PTD |
phosphotransferase domain of KIT |
SM |
systemic mastocytosis |
SM-AHN |
Systemic mastocytosis with associated hematologic neoplasm |
MCS |
Mast cell sarcoma |
TPSAB1
|
Genes encoding α- and β-tryptases |
MCAS |
MC activation syndrome |
MRGPRX2 |
Mas-related G protein-coupled receptor |
NRAS |
NRAS Proto-Oncogene, GTPase |
PLCG2 |
Phospholipase Cγ2
|
RUNX1 |
RUNX Family Transcription Factor 1 |
SCF |
Stem cell factor |
SF3B1 |
Splicing Factor 3b Subunit 1 |
SRSF2 |
Serine And Arginine Rich Splicing Factor 2 |
TET2 |
Tet Methylcytosine Dioxygenase 2 |
TLR |
Toll-like receptor |
U2AF1 |
U2 Small Nuclear RNA Auxiliary Factor 1 |
WDSM |
well-differentiated systemic mastocytosis |